Moderna earnings, retail sales data, FedSpeak: What to Watch
Julie Hyman and Josh Lipton preview the biggest earnings stories and economic data due out tomorrow, Friday, February 14. Pharmaceutical company Moderna (MRNA) and energy provider Enbridge (ENB) are ...
Moderna, Inc.: Working Hard But Competition Is Working Harder
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...
Moderna price target lowered to $25 from $35 at Wolfe Research
Wolfe Research lowered the firm’s price target on Moderna (MRNA) to $25 from $35 and keeps an Underperform rating on the shares. The firm ...
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Moderna (MRNA) Expected to Announce Quarterly Earnings on Friday
Moderna (NASDAQ:MRNA – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Friday, February 14th. Analysts expect the company to announce earnings of ($2.
1 Stock to Buy, 1 Stock to Sell This Week: Robinhood, Moderna
Inflation data, Powell testimony, more earnings will be in focus this week. • Robinhood’s strong financial health, robust ...